- Home
- RCON vs ABOS Comparison
RCON vs ABOS Comparison
Compare RCON & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- ABOS
- Stock Information
- Founded
- RCON 2007
- ABOS 1996
- Country
- RCON China
- ABOS United States
- Employees
- RCON N/A
- ABOS N/A
- Industry
- RCON Oilfield Services/Equipment
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- RCON Energy
- ABOS Health Care
- Exchange
- RCON Nasdaq
- ABOS Nasdaq
- Market Cap
- RCON 60.5M
- ABOS 72.7M
- IPO Year
- RCON 2009
- ABOS 2021
- Fundamental
- Price
- RCON $2.55
- ABOS $1.16
- Analyst Decision
- RCON
- ABOS Strong Buy
- Analyst Count
- RCON 0
- ABOS 4
- Target Price
- RCON N/A
- ABOS $6.50
- AVG Volume (30 Days)
- RCON 295.2K
- ABOS 571.8K
- Earning Date
- RCON 07-07-2025
- ABOS 08-12-2025
- Dividend Yield
- RCON N/A
- ABOS N/A
- EPS Growth
- RCON N/A
- ABOS N/A
- EPS
- RCON N/A
- ABOS N/A
- Revenue
- RCON $8,996,572.00
- ABOS N/A
- Revenue This Year
- RCON N/A
- ABOS N/A
- Revenue Next Year
- RCON $12.17
- ABOS N/A
- P/E Ratio
- RCON N/A
- ABOS N/A
- Revenue Growth
- RCON N/A
- ABOS N/A
- 52 Week Low
- RCON $1.35
- ABOS $0.86
- 52 Week High
- RCON $3.70
- ABOS $3.60
- Technical
- Relative Strength Index (RSI)
- RCON 56.36
- ABOS 48.75
- Support Level
- RCON $2.42
- ABOS $1.12
- Resistance Level
- RCON $2.75
- ABOS $1.26
- Average True Range (ATR)
- RCON 0.30
- ABOS 0.08
- MACD
- RCON 0.00
- ABOS -0.01
- Stochastic Oscillator
- RCON 55.56
- ABOS 30.77
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.